Abstract
Background:
Shyonaka (Oroxylum indicum Vent.; Bignoniaceae) root bark is one of the ingredients of dashamoola (a group of 10 roots), and is used for its anti-inflammatory and analgesic action in a number of compound formulations in Ayurveda.
Aim:
Ayurvedic Pharmacopoeia of India (API) recommends using the stem bark instead of root bark.
Material and Methods:
An attempt has been made to study the anti-inflammatory activity of both root bark and stem bark kashaya (decoction) experimentally.
Conclusion
Results showed significant anti-inflammatory activity of root bark and stem bark decoction.
Keywords: Anti-inflammatory, Ayurveda, dashamoola, Oroxylum indicum, shyonaka
INTRODUCTION
Root bark of Shyonaka (Oroxyllum indicum Vent..; Bignoniaceae) is one of the ingredient of Dashamoola and is found in many of the compound formulations in Ayurveda, which have been advocated with promising results in various diseases.[1] Dashamoola is known for its anti-inflammatory, anti-helminthic, anti-bronchitis, anti-leukodermatic, antirheumatic, antianorexic activity and for treatment of leprosy and tuberculosis, etc.[2,3] Apart from its use as an ingredient in dashamoola, shyonaka is used as a single drug internally and externally in sotha (~ inflammation), amavata (~ rheumatoid arthritis), and various other ailments.[4] It is one of the ingredients in many important Ayurvedic formulations, such as Dasamoolaristam, Dasamoola rasayanam, Amrutaristam, Chyavanaprasa , and others.[5] Owing to the indiscriminate collection, overexploitation and uprooting of whole plants bearing roots, this valuable tree has become vulnerable in many states of India.[6,7] Existence of O. indicum in natural population is highly threatened and has been categorized as vulnerable medicinal plant by the Government of India.[8]
Various parts of this plant are utilized to cure many diseases. Leaves are emollient, that contain anthraquinone and aloe-emodin.[9] Fruits are used in treating bronchitis, leukoderma, and helminthosis.[10] Seed extract exhibits antimicrobial, analgesic, antitussive, and anti-inflammatory properties.[11] Many flavones and traces of alkaloids are present in pods, seeds, stem, and root bark.[12] Chemical studies of O. indicum led to the isolation of ellagic acid,[13] 5,7-dihydroxy flavones (chrysin),[14] 5-hydroxy-8-methoxy-7-0-β-D-glucopyranuronosyl flavone,[15] stigmast-5-en-3-ol,[16] 5,6,7-trihydroxy flavone (baicalein),[17,18] 3, 4′, 5, 7-tetrahydroxy-flavonol.[19]
Ayurvedic Pharmacopoeia of India (API)[20] advocates using stem bark of O. indicum in place of its root bark. According to Ayurveda root bark of shyonaka is used in different dosage forms, such as kwatha (decoction), churna (powder), and others.[21] Ancient Ayurvedic literature opines that the properties and actions attributed to one part of the plant will be the same for the other parts too.[22] Few studies on anti-inflammatory activity of the extract of O. indicum stem bark have been reported.[23] But no work has been reported regarding the comparative anti-inflammatory activity of stem bark and root bark of shyonaka . Here an attempt has been made to compare the anti-inflammatory activity of root bark and stem bark of Shyonaka.
MATERIALS AND METHODS
Selection of experimental model
Winter et al.[24] experimental model was adopted in which carrageenan was used to produce the paw edema.
Collection of the trial drugs
The root bark and stem bark of Shyonaka was collected from Dang district of Gujarat after proper botanical identification with the help of pharmacognosist. A voucher specimen of the trial drugs was preserved in the museum of the Department of Dravyaguna, I.P.G.T. and R.A., Jamnagar.
Instruments and chemicals used
Instruments such as weighing machine, monopan balance, syringe, needle, catheters, plethysmometer, and the chemicals like carrageenan, normal saline were used for the experimental study.
Pharmaceutical method of the trial drug
The obtained root bark and stem bark were shade dried and made into coarse powder. One part of the trial drug and 16 parts of water was taken in a clean vessel and boiled till it was reduced to 1/8th of the initial quantity. It was then filtered through a clean cloth to obtain the kashaya (decoction). [25]
Dose fixation and schedule
Human dose of shyonaka root bark is 25 g and it has to be administered as decoction with dosage 50 mL, t.d.s. [26] Decoction was prepared by standard procedure. Human dose is 150 mL/day. However, to establish dose form for experimental purposes, rat dose calculation was done on the basis of body surface area ratio using the table of Paget and Barnes.[27] The animal dose of decoction was fixed as 14 mL/kg body weight. The trial drugs and vehicle to control group were administered according to the body weight of the animals orally with the help of gastric catheter of suitable size, sleeved to a syringe nozzle.
Animals and grouping
Wistar strain albino rats of either sex, weighing between 160 and 200g were used for experimental study. The animals were obtained from the animal house attached to the pharmacology laboratory of I.P.G.T. and R.A. Animals were exposed to natural day and night cycles with ideal laboratory condition in terms of ambient temperature (25°C±2°C) and humidity (50%-60%). They were fed with Amrut brand rat pellet feed supplied by Pranav Agro Industries and tap water was given ad libitum. The experiment was carried out after obtaining permission from Institutional Animal Ethics Committee (Vide No. IAEC-04/08-10/M.Pharm.04).
The 18 animals, irrespective of sex were randomly grouped into 3 groups. They are Group A (water control), Group B (root bark decoction of Shyonaka), and Group C (stem bark decoction of Shyonaka) and each group comprised 6 animals.
Experimental procedure
Animals in group A were kept under water control. The animals in groups B and C were administered with trial drugs root bark and stem bark decoction of shyonaka , respectively, for 5 days at the dose of 14 mL/kg orally. On fifth day, 1 h after drug administration, initial paw volume was recorded and edema was induced in the right paw by injecting 0.1 ml freshly prepared 1% carrageenan in sterile saline solution into subplantar aponeurosis of the hind limb. After injection the rats were administered tap water in the dose of 2 ml/100 g body weight to ensure uniform hydration and hence to minimize variations in edema formation. Paw volume was recorded with the help of plethysmometer after 3 h after carrageenan injection.
Statistical analysis
Results were expressed as Mean±SEM. Student′s unpaired t test was used for analyzing the data. P<0.01 was considered as statistically significant.
RESULTS AND DISCUSSION
Being an ingredient of dashamoola, generally root bark of shyonaka is officially considered to be the part of the plant to be used in medicinal preparations in Ayurveda.[28] A certain Ayurvedic classical text advocates that the properties and actions of different parts of the plant are same.[22] Recent studies proved that major chemical constituents of O. indicum Vent. like Oroxylum-A, Chrysin, and Baicalein were presented in alcoholic and water extract of root bark and stem bark.[29]
Both root bark and stem bark decoction produced a considerable suppression in edema formation against carrageenan in comparison to the control group. Statistically significant decrease in paw edema was observed in both the groups (groups A and B) of Shyonaka decoction in comparison to the control group [Table 1]. The percentage of suppression of edema in group A is 26.30% and 22.70% in group B. The magnitude of suppression observed in decoction prepared from stem bark (Group B) is more than root bark (Group A) [Table 1 and Figure 1]. So, stem bark decoction of shyonaka can be used as anti-inflammatory drug.
Table 1.
CONCLUSION
Root bark and stem bark of Shyonaka (O. indicum ) provides significant anti-inflammatory activity. Hence, in the place of root bark, stem bark can be substituted. However, clinical studies should be carried out to prove the same.
Footnotes
Source of Support: Nil,
Conflict of Interest: None declared.
REFERENCES
- 1.Sharma PV. Vol. 1. Varanasi: Chaukhamba Bharati Academy; 2006. Dravyaguna vijnana; p. 125. [Google Scholar]
- 2.Manonmani S, Vishwanathan VP, Subramanian S, Govindasamy S. Biochemical studies on the antiulcerogenic activity of Cauvery 100, an Ayurvedic formulation in experimental ulcers. Indian J Pharmacol. 1995;27:101–5. [Google Scholar]
- 3.Bhattacharjee SK. Jaipur: Pointer Publishers; 2000. Hand book of aromatic plants. [Google Scholar]
- 4.Chunekar KC, Pandey GS. 10th ed. Varanasi: Chaukhamba Bharati Academy; 1999. Bhavaprakasha Nighantu; pp. 283–5. [Google Scholar]
- 5.Mumbai: Regional Research Laboratory, Jammu and Indian Drug Manufacturer's Association; 1998. Anonymous. The Herbal Pharmacopoeia of India; p. 165. [Google Scholar]
- 6.Darshan S, Ved DK. A balanced perspective for management of Indian Medicinal Plants. Indian For 2003. 129:275–8. [Google Scholar]
- 7.Jayram K, Prasad MN. Genetic diversity in Oroxylum indicum (L) Vent.(Bignoniaceae) a vulnerable medicinal plant by random amplified polymorphic DNA marker. Afr J Biotechnol. 2008;7:254–62. [Google Scholar]
- 8.Ravi Kumar K, Ved DK. 100 Red listed medicinal plants of conservation concern in Southern India.Bangalore: Foundation for revitalisation of local health traditions; 2000. :1–467. [Google Scholar]
- 9.Nakahara K, Roy MK, Alzoreky NS, Na-Thalang V, Trakoontivakorn G. Inventory of indigenous plants and minor crops in Thailand based on bioactivities.9 th JIRCAS International Symposium-value addition to Agricultural Product. 2002:135–9. [Google Scholar]
- 10.Parrotta JA. New York,USA: CABI Publishers; 2001. Healing plants of Peninsular India. [Google Scholar]
- 11.Rasadah MA, Houghton PJ, Amala R, Hoult JR. Antimicrobial and anti-inflammatory activity of extracts and constitutes of Oroxylum indicum Vent. Phytomedica. 1998;5:375–81. [Google Scholar]
- 12.Uddin K, Sayeed A, Islam A, Rahman AA, Ali A, Khan GR, et al. Purification, characterization and cytotoxic activity of two flavonoids from Oroxylum indicum Vent.(Bignoniaceae) Asian J Plant Sci. 2003;2:515–8. [Google Scholar]
- 13.Maitreyi Z, Khandhar A, Jain S. Quantification of Baicalein, Chrysin, Biochanin-A and Ellagic Acid in Root Bark of Oroxylum indicum by RP-HPLC with UV Detection. Eur J Anal Chem. 2008;3:245–57. [Google Scholar]
- 14.Babu KS, Babu TH, Srinivas PV, Kishore KH, Murthy US, Rao JM. Synthesis and biological evaluation of novel C (7) modified chrysin analogues as antibacterial agents. Bioorg Med Chem Lett. 2006;16:221–4. doi: 10.1016/j.bmcl.2005.09.009. [DOI] [PubMed] [Google Scholar]
- 15.Nair AG, Joshi BS. Oroxindin - A new flavone glucuronide from Oroxylum indicum Vent. J Chem Sci. 1979;88A:323–7. [Google Scholar]
- 16.Rasadah A, Houghton M, Raman PJ. Antimicrobial and antiinflammatory activities of extracts and constituents of Oroxylum indicum. Phytomedicine. 1998;5:375–81. doi: 10.1016/S0944-7113(98)80020-2. [DOI] [PubMed] [Google Scholar]
- 17.Chen L, Song H, Du Q, Jianrong L, Ito Y. Analysis of Flavonoids in the Extracts from the Seeds of Oroxylum indicum using high speed countercurrent Chromatography/Mass Spectrometry. J Liq Chrom Relat Technol. 2005;28:1549–55. [Google Scholar]
- 18.Chen LJ, Games DE, Jonathan J. Isolation and identification of four flavonoid constituents from the seeds of Oroxylum indicum by high-speed counter-current chromatography. J Chromat A. 2003;988:95–105. doi: 10.1016/s0021-9673(02)01954-4. [DOI] [PubMed] [Google Scholar]
- 19.Kaisarul Islam M, Zahan Eti I, Ahmed Chowdhury J. Phytochemical and Antimicrobial Analysis on the Extract of Oroxylum indicum Linn.Stem-Bark. Iran J Pharmacol Ther. 2010;9:25–8. [Google Scholar]
- 20.1st ed. New Delhi: Govt. of India, Ministry of Health and Family welfare; 2007. Anonymous. The Ayurvedic Pharmacopoeia of India, Part 2, Vol. 1., Formulations; p. 55. (65, 135). [Google Scholar]
- 21.2nd ed. Vol. 3. New Delhi: Govt. of India, Ministry of Health and Family Welfare; 2000. Anonymous. The Ayurvedic Formulary of India, 1; pp. 210–1. [Google Scholar]
- 22.Bhatta K, Swami L, editors. 2nd ed. Varanasi: Krishnadas Academy; 1999. Sidhabheshaja Manimala; p. 7. [Google Scholar]
- 23.Laupattarakasem P, Houghton PJ, Hoult JR, Itharat A. An evaluation of the activity related to inflammation of four plants used in Thailand to treat arthritis. J Ethnopharmacol. 2003;85:207–15. doi: 10.1016/s0378-8741(02)00367-7. [DOI] [PubMed] [Google Scholar]
- 24.Winter CA, Risley EA, Nuss GW. Carrageenan induced edema in hind paw of rat as an assay for antiinflammatory drugs. Proc Soc Exp Biol. 1962;111:544. doi: 10.3181/00379727-111-27849. [DOI] [PubMed] [Google Scholar]
- 25.Srivastava S. 1st ed. Varanasi: Chaukhamba Orientalia; 1996. Sharangadhara. Sharangadhara Samhitha; p. 135. [Google Scholar]
- 26.1st ed. Vol. 3. New Delhi: Govt. of India, Ministry of Health and Family Welfare; 2007. Anonymous. The Ayurvedic Pharmacopoeia of India, Part 1; pp. 210–1. [Google Scholar]
- 27.Paget GE, Barnes JM. Evaluation of drug activities, Pharmacometrics. In: Lawranle DR, Bacharch AL, editors. Vol. 1. New York: Academic Press; 1964. [Google Scholar]
- 28.Sharma PV. Vol. 2. Varanasi: Chaukhamba Bharati Academy; 2001. Dravyaguna Vijnana; pp. 469–71. [Google Scholar]
- 29.Doshi K, Ilanchezhian R, Acharya R, Patel BR, Harisha CR, Shukla VJ. A comparative phyto-pharmacognostical evaluation of stem and root of shyonaka ( Oroxylum indicum Linn.) Int Res J Pharm. 2011;2:66–73. [Google Scholar]